- Home
- BBOT vs DEA Comparison
BBOT vs DEA Comparison
Compare BBOT & DEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBOT | DEA |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | BBOT | DEA |
|---|---|---|
| Price | $9.17 | $23.22 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | ★ $24.00 | $23.49 |
| AVG Volume (30 Days) | 228.0K | ★ 339.2K |
| Earning Date | 05-26-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 7.76% |
| EPS Growth | N/A | ★ 50.00 |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $336,099,000.00 |
| Revenue This Year | N/A | $5.20 |
| Revenue Next Year | N/A | $3.63 |
| P/E Ratio | ★ N/A | $85.81 |
| Revenue Growth | N/A | ★ 11.27 |
| 52 Week Low | $8.08 | $7.88 |
| 52 Week High | $14.87 | $24.94 |
Technical Indicators
Market Signals| Indicator | BBOT | DEA |
|---|---|---|
| Relative Strength Index (RSI) | 48.70 | 63.75 |
| Support Level | $8.80 | $21.64 |
| Resistance Level | $12.36 | $23.70 |
| Average True Range (ATR) | 0.57 | 0.45 |
| MACD | 0.08 | 0.24 |
| Stochastic Oscillator | 72.40 | 98.69 |
Price Performance
Historical ComparisonAbout BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.
About DEA Easterly Government Properties Inc.
Easterly Government Properties Inc is a real estate investment trust. The company is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. It generates all its revenue by leasing its properties to such agencies. The company operates in single segment for the purposes of assessing performance and making operating decisions.